NASDAQ:DVAX - Dynavax Technologies Corporation
$3.35
 $-0.31
-8.47%
4:00PM EDT
2019-07-22
Dynavax Technologies Corporation (Dynavax), incorporated on November 6, 2000, is a clinical-stage immunotherapy company focused on leveraging the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. The Company's product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of hepatitis B and as a disease modifying therapy for asthma. The Company's pipeline of product candidates includes HEPLISAV-B, AZD1419, SD-101, DV281, DV230F and DV1001. DV230F is indicated for the treatment of Liver Tumors. DV1001 targets TLR 7 and 8 agonist for multiple malignancies. DV230F and DV1001 are in pre-clinical stage of development.HEPLISAV-BThe Company's product candidate HEPLISAV-B is an investigational adult hepatitis B vaccine. HEPLISAV-B combines 1018, a TLR9 agonist adjuvant, and recombinant hepatitis B surface antigen (rHBsAg). HEPLISAV-B is in Phase III of its clinical trials.AZD1419AZD1419 is being developed for the treatment of asthma pursuant to a collaboration with AstraZeneca AB (AstraZeneca). AZD1419 is designed to change the basic immune response to environmental allergens, such as house dust and pollens, leading to prolonged reduction in asthma symptoms by converting the response from one primarily mediated by type-2 helper thymus (T) cells to type-1 helper T cells. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  DVAX     avg for
industry  
  avg for
sector  
42 stocks weight:  17. 79   0. 00   0. 00  
42 stocks rank:  3. 45 K 1. 35 K 799. 74  
# analyst opinions:  5. 00   12. 76   13. 14  
mean recommendation:  1. 80   2. 11   2. 07  

quick ratio:  4. 47   5. 61   1. 85  
current ratio:  5. 27   6. 00   2. 31  

target price low:  2. 86   75. 88   108. 31  
target price avg:  4. 14   97. 27   130. 10  
target price high:  4. 20   124. 58   149. 02  
1-yr high:  14. 30   104. 89   135. 09  
last close:  3. 35   79. 79   118. 76  
50-day avg:  4. 62   79. 39   116. 18  
200-day avg:  8. 47   81. 61   114. 52  
1-yr low:  3. 35   62. 76   94. 70  
volume:  573. 93 K 2. 99 M 4. 43 M
50-day avg volume:  1. 52 M 3. 39 M 4. 22 M
200-day avg volume:  1. 24 M 3. 13 M 4. 83 M

1-day return:  -8. 47 % 0. 33 % 0. 14 %
this week return:  -8. 47 % 0. 33 % 0. 14 %
12-wk return:  -51. 87 % 1. 00 % 3. 51 %
52-wk return:  -76. 39 % 0. 58 % 10. 25 %

enterprise value (EV):  267. 56 M 44. 78 B 115. 63 B
market cap:  217. 97 M 38. 01 B 103. 29 B
EBITDA:  -137. 64 M 4. 47 B 7. 73 B
enterprise multiple (EV/EBITDA):  -1. 94   2. 11   11. 26  
enterprise/revenue (EV/R):  19. 38   61. 53   10. 40  
total revenue:  13. 81 M 10. 43 B 31. 15 B
total debt:  212. 63 M 11. 72 B 16. 76 B
debt/equity:  492. 67   61. 22   124. 43  
net income (common):  -159. 61 M 2. 06 B 3. 79 B

shares outstanding:  65. 07 M 562. 08 M 1. 27 B
shares:  57. 37 M 573. 33 M 1. 26 B
shares short:  13. 74 M 11. 60 M 12. 29 M
shares short prior month:  15. 76 M 9. 81 M 12. 46 M
short ratio:  8. 81   5. 88   3. 41  
short % of float:  21. 97 % 6. 88 % 2. 72 %
total cash/share:  2. 82   10. 62   8. 83  
total cash:  183. 22 M 6. 17 B 5. 72 B
free cash flow:  -94. 53 M 3. 08 B 3. 10 B
operating cash flow:  -141. 33 M 3. 99 B 4. 08 B

book value:  0. 66   12. 74   26. 25  
price/book:  5. 05   4. 38   9. 01  
gross profits:  -77. 69 M 7. 93 B 35. 64 B
operating margins:  -1107. 19 % -319. 65 % -29. 05 %
EBITDA margins:  0. 00 % 11. 82 % 24. 13 %
profit margins:  0. 00 % 5. 62 % 14. 29 %
gross margins:  0. 00 % 34. 75 % 57. 07 %

1-yr max volatility:  18. 07 % --- ---
1-yr mean volatility:  2. 97 % 1. 95 % 1. 25 %

1-yr EPS:  -2. 54   1. 58   3. 82  
forward EPS:  -0. 96   3. 16   6. 65  
P/E:  -1. 32   0. 21   31. 97  
forward P/E:  -3. 81   4. 95   15. 14  
PE/G:  -0. 00   0. 74   0. 13  
growth:  3398. 80 % 295. 81 % 85. 47 %
earnings high:  -0. 46   0. 84   1. 56  
earnings avg:  -0. 56   0. 65   1. 45  
earnings low:  -0. 64   0. 40   1. 35  
revenue high:  12. 75 M 2. 70 B 8. 76 B
revenue avg:  9. 14 M 2. 64 B 8. 62 B
revenue low:  7. 75 M 2. 58 B 8. 45 B
return on assets:  -32. 28 % -3. 43 % 4. 51 %
return on equity:  -152. 71 % -104. 30 % 140. 44 %
revenue growth:  3398. 80 % 295. 25 % 78. 55 %
revenue/share:  0. 22   12. 50   51. 58  

beta (1yr vs S&P500):  1. 44   1. 27   0. 91  
sharpe (1yr):  -2. 10   0. 20   0. 80  

held % insiders:  1. 19 % 6. 63 % 3. 46 %
held % institutions:  85. 10 % 76. 45 % 67. 87 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-22 : DVAX
.    101.469 =       101.469 :: --> INITIAL WEIGHT <--
.    - 2.539 =         98.93 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.485 =       245.847 :: P/E factor
.    x 2.209 =       543.065 :: PE/G factor
.    x 1.577 =       856.555 :: beta factor
.    x 0.719 =       615.859 :: sharpe factor
.    x 2.878 =      1772.138 :: current ratio factor
.    x 1.135 =       2011.15 :: quick ratio factor
.    x 1.055 =      2122.223 :: short ratio factor
.    x 4.512 =      9575.548 :: revenue growth factor
.    x 1.315 =     12591.464 :: EV/R factor
.    x 1.062 =     13375.656 :: price-to-book factor
.     x 0.66 =       8830.79 :: debt-to-revenue factor
.    x 2.328 =     20561.665 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.759 =     56734.463 :: sector+industry 1-year gains factor
.     x 1.01 =      57300.96 :: industry 12-weeks return factor
.    x 1.309 =     75027.956 :: industry 2-weeks return factor
.    x 0.974 =     73079.872 :: "drift" penalty 1 days ago
.    x 0.976 =     71323.199 :: "drift" penalty 3 days ago
.    x 0.958 =     68302.549 :: "drift" penalty 5 days ago
.    / 2.045 =     33406.208 :: overall "drift" factor
.    x 0.757 =     25301.715 :: largest single-day jump factor
.    x 0.072 =       1829.48 :: low price factor
.    x 0.143 =       262.304 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.922 =       241.739 :: forward EPS factor
.    x 0.972 =       234.852 :: forward P/E factor
.    x 1.184 =       278.056 :: industry recommendation factor
.    x 2.389 =       664.259 :: company recommendation factor
.    x 1.002 =       665.268 :: factor historical industry gain for week 29
.    x 0.942 =       626.436 :: target low factor
.    x 1.162 =       727.712 :: target mean factor
.    x 1.021 =       743.108 :: target high factor
.    x 4.584 =      3406.354 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =          7.64 :: reduced for readability
.   + 10.149 =        17.788 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     17.788 :: FINAL WEIGHT for NASDAQ:DVAX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org